Get the Stockscreener App
1.84
2.22%
0.04
Pre-market:
1.95
0.11
+5.98%
Heartsciences Inc stock is traded at $1.84, with a volume of 148.95K.
It is up +2.22% in the last 24 hours and up +1.66% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$1.80
Open:
$1.84
24h Volume:
148.95K
Relative Volume:
5.24
Market Cap:
$5.86M
Revenue:
$8,700
Net Income/Loss:
$-8.49M
P/E Ratio:
-0.3732
EPS:
-4.9303
Net Cash Flow:
$-7.39M
1W Performance:
+0.00%
1M Performance:
+1.66%
6M Performance:
-25.51%
1Y Performance:
-48.51%
1-Day Range:
$1.80
$2.085
1-Week Range:
$1.74
$2.085
52-Week Range:
$1.63
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
1.84 | 5.86M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Stock (HSCS) Latest News
HSCS Q1 2026 Earnings: EPS Beat Surprise of 27% on Lower-Than-Expected Loss, No Revenue ReportedGrowth Acceleration Report - newsline.com
AI ECG heart test secures patent protection in 19 European countries - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
HeartSciences Inc. Financial Disclosures & SEC Filings - TradingView
HeartSciences Launches New Version of MyoVista Insights with AI-ECG - dicardiology.com
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm - The Manila Times
AI heart scan helping spot heart failure risk earns $136 Medicare payment - Stock Titan
HeartSciences Inc. (HSCS) Slides 6.96% as Stock Approaches Critical Support at $1.59Dealer Positioning - The Legal Advocate
HeartSciences Warrants (HSCSW) Remain Flat at $0.05 as Support and Resistance CoincideDark Pool Prints - newsline.com
HeartSciences Inc. (HSCS) Declines Over 7% as Stock Tests Key Support Near $1.70Early Entry Signals - The Legal Advocate
HSCS Q1 2026 Earnings: EPS Beat Amid Cost‑Discipline, but Revenue Void Weighs on SentimentTech Earnings Analysis - newsline.com
HeartSciences Inc. (HSCS) Slips 2.5% as Shares Test Key Support ZoneProfit Surge Picks - The Legal Advocate
HeartSciences Inc. Warrant (HSCSW) Slides 15.50% as Price Narrows to $0.05TPO Profile - The Legal Advocate
HeartSciences Inc. Warrant (HSCSW) Slides 15% as Price Hovers at Key $0.05 LevelPut Flow Alert - The Legal Advocate
HeartSciences Inc. (HSCS) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost Control, Shares RallyAdjusted Earnings Analysis - The Legal Advocate
HSCS Q1 2026 Earnings: EPS Surpasses Estimates as HeartSciences Advances Development PipelineEarnings Growth Analysis - newsline.com
HeartSciences signs North Shore Health for MyoVista platform - Investing.com UK
HeartSciences signs North Shore Health for MyoVista platform By Investing.com - Investing.com Nigeria
Rural Minnesota hospital adopts AI ECG platform endorsed by 127-hospital network - Stock Titan
HeartSciences (HSCS) Rallies +3.99% as Bulls Target $1.94 2026-05-18Undervalued Stocks - newsline.com
HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks
HeartSciences (HSCSW) Stalls at $0.06 — Breakout or Breakdown? 2026-05-17Fibonacci Entry Signals - newsline.com
HeartSciences (HSCS) Reports Strong Q1 2026 — Revenue $N/A, EPS BeatsMarket Hype Signals - newser.com
TradingKey - TradingKey
HeartSciences (HSCS) Stock: Slides -3.53%, Support at $1.74 2026-05-14Gamma Alerts - Newser
HeartSciences (HSCSW) Stalls at $$0.06 — Breakout or Breakdown? 2026-05-14Collaborative Trading Signals - newser.com
What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com
What HeartSciences (HSCSW) disclosed about liquidity position | HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataEarnings Risk - Newser
HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataQuarterly Financial Update - The Legal Advocate
The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableFinancial Health - Newser
HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com
HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart
HeartSciences (NASDAQ: HSCS) 2026 meeting backs director, auditor, adjournment - Stock Titan
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
Heartsciences Signs Commercial Agreement with St. Vincent Health for MyoVista Insights SaaS Deployment - marketscreener.com
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):